P6, who had PHP1a, experienced an increase in their growth rate in response to GH treatment, but P9, who had PPHP and was initially diagnosed with ISS, demonstrated no response to their rhGH therapy. The gene discussed is GH1; the disease is pseudopseudohypoparathyroidism.